Inside Scope: Recent Episodes
American Gastroenterological Association (AGA)
Welcome to Inside Scope, the American Gastroenterological Association podcast that will help you advance your patient care, one half-hour segment at a time. Join us to hear from the experts, learn new skills, and stay abreast of changing best practices in gastroenterology patient care.
Welcome to episode five of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion focused on distinguishing the overlapping symptoms of irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) from inflammatory bowel disease (IBD). The conversation will examine how these conditions influence dietary choices and food-related quality of life (FRQoL), highlighting the clinical and psychosocial challenges patients often face. Listeners will gain practical insights into evidence-based approaches for both short-term and long-term management of IBS and SIBO, with an emphasis on individualized care strategies that minimize unnecessary dietary restriction while supporting symptom control and improved patient outcomes. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer.
Welcome to the final episode in our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion addressing common myths and misinformation surrounding diet and nutrition in inflammatory bowel disease (IBD). The conversation will explore frequently debated topics, including the role of gluten and dairy in IBD-related inflammation, the evidence behind food intolerance testing, and perceptions around organic versus conventional foods and their impact on health. Listeners will gain evidence-based clarity to help dispel nutrition myths, counsel patients with confidence, and support informed, balanced dietary decision-making in the management of IBD. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer.
Welcome to episode four of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, introduce the principles of Enhanced Recovery After Surgery (ERAS) and discuss how this evidence-based framework applies to the perioperative care of patients with inflammatory bowel disease (IBD). The conversation will explore the unique considerations for individuals with IBD undergoing surgery and highlight key strategies used to optimize surgical outcomes, including perioperative nutritional support, multidisciplinary care coordination, and patient-centered recovery planning. Listeners will gain practical insights into how ERAS principles can be integrated into clinical practice to support improved recovery, reduced complications, and better overall surgical outcomes for patients with IBD. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer.
Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode two, “MASH: How to Treat and When to Refer,” Drs. Arun Sanyal and Mary Rinella take a look at the role that primary care physicians can play in the treatment of MASH, how can they treat and monitor these patients, and most importantly, when should a specialist be called in. Our experts will review current treatment guidelines and care pathways for MASH. They’ll discuss the role of PCPs in the multidisciplinary management of patients with MASH, including the referral of high-risk patients to specialists. Finally, they’ll share the management of underlying metabolic conditions, such as T2DM and obesity, in patients with MASH who are at low risk of fibrosis. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting : https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. In episode one, “Recognizing a ‘Silent’ Disease,” Drs. Arun Sanyal and Mary Rinella will discuss MASH and the role that primary care physicians can play in its early detection and treatment. What are the challenges in diagnosing this often-silent disease? What do clinicians need to know to ensure that MASH doesn't fall off their radar? Listen as experts discuss challenges in MASLD/MASH diagnosis, including risk stratification of patients, and implications for diagnostic delays. Additionally, they’ll share strategies for incorporating noninvasive methods such as the FIB-4 score, NFS, APRI, and secondary assessments. Finally, the experts will emphasize the vital role PCPs play in MASH detection and management. This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting: https://suitehome.atpointofcare.com/library/2711.01/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
Welcome to episode three of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Victoria Christianson, RD, to explore the critical topic of malnutrition in inflammatory bowel disease (IBD). The discussion will begin with practical approaches to screening and assessment, highlighting key red flags that clinicians should recognize in both outpatient and inpatient settings. The conversation will then delve into the dual challenges of sarcopenia and obesity, examining how variations in fat mass can influence the clinical course of IBD and impact patient outcomes. Listeners will gain insights into the nuances of managing nutrition for ambulatory versus hospitalized patients, including considerations for those with NPO status. The episode will provide actionable strategies for identifying at-risk patients, tailoring interventions, and collaborating with multidisciplinary teams to optimize nutritional care across the continuum of IBD management. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer
Welcome to episode one of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by guest Dr. Dale Lee to discuss the role of diet as a therapeutic approach for managing inflammatory bowel disease (IBD). The discussion will cover the distinction between symptoms and disease control, the use of enteral nutrition therapies, and the benefits of whole food-based diets. We will explore how exclusive enteral nutrition can be used to treat conditions like Crohn's disease and the importance of a close partnership with a dietitian. Our experts will also address the challenges and opportunities of using dietary therapy for IBD, including differences in nutritional therapy for adult versus pediatric patients and the future landscape of nutrition and IBD management. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org This independent educational program was supported by an independent medical education grant from Pfizer
Welcome to episode two of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Rotem Sigall Boneh, RD, to explore the essential aspects of integrating nutritional expertise into inflammatory bowel disease (IBD) management. This episode will cover how to effectively collaborate with a GI dietitian, emphasizing strategies for personalizing dietary interventions to ensure the right diet is matched to the right patient at the right time. Additionally, the group discusses the practicalities of referring patients to a dietitian and clarifies the differences between a nutritionist and a registered dietitian, helping health care providers make informed decisions about patient care. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.orgThis independent educational program was supported by an independent medical education grant from Pfizer
There is some debate about when to recommend cessation of surveillance colonoscopy, especially in those who are 75-85 years old. In this episode of the AGA Perspectives series, Dr. Gyanprakash Ketwaroo and Dr. Moamen Gabr are joined by Dr. Mariam Naveed and Dr. Petr Protiva to discuss this common but tricky topic.
Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.
In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Drs. Kevin Garey and Melissa Passarello to discuss the impact of recurrent CDI on patients and their lives.
This episode does not offer Continuing Medical Education (CME) credits.
This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.
Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.
In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Rebecca Perez and Cheri Lattimer to discuss case management and transitions of care in C. difficile infection.
You can now claim CME for listening – visit agau.gastro.org.
This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.
Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.
In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Colleen Kelly to discuss how to reconcile guideline differences for testing and treatment of C. difficile.
You can now claim CME for listening – visit agau.gastro.org.
This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.
This special episode of Inside Scope shares recommendations from the AGA Clinical Practice Update (CPU) on the Endoscopic Approach to Recurrent Acute and Chronic Pancreatitis. Our host Jana Al Hashash, MD, is joined by subject matter expert Greg Cote, MD, MS, and CPU authors Daniel Strand, MD, and Ryan Law, DO.
In honor of C. diff Awareness Month, we're launching two bonus episodes from our upcoming program: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.
In this bonus episode, Drs. Paul Feuerstadt and Sahil Khanna cover risk factors for initial and recurrent C. difficile infection.
This series is supported by an educational grant from Ferring Pharmaceuticals, Inc.
In honor of C. diff Awareness Month, we're launching two bonus episodes from our upcoming program: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.
In this bonus episode, Drs. Paul Feuerstadt and Sahil Khanna describe the shifts in the microbiota with C. difficile infection.
This series is supported by an educational grant from Ferring Pharmaceuticals, Inc.
This is episode 2 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about strategies for promoting initiation of colorectal cancer screening at age 45 and addressing early-onset colorectal cancer.
In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center • Samir Gupta, MD, associate professor of clinical medicine at the University of California San Diego and the San Diego Veterans Affairs Healthcare System
This season is supported by an independent medical education grant from Exact Sciences.
This is episode 4 of our 5-part series Colorectal Cancer: Screening to Save Lives. We talk about important considerations when caring for individuals at high risk for poor outcomes in colorectal cancer due to social determinants of health.
In this episode:
• David Lieberman, MD, professor of medicine in the division of Gastroenterology and Hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center
This season is supported by an independent medical education grant from Exact Sciences.
In our final episode of our 5-part series Colorectal Cancer: Screening to Save Lives, we share updated information about coverage, cost-sharing, reimbursement and coding for colorectal cancer screening.
In this episode:
• David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center • Shivan Mehta, MD, assistant professor of medicine and health policy at Perelman School of Medicine and associate chief innovation officer at Penn Medicine Center for Innovation
This season is supported by an independent medical education grant from Exact Sciences.
This is episode 1 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode covers what clinicians need to know regarding the updated colorectal cancer screenings guidance from the U.S. Preventive Services Task Force.
In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center
This season is supported by an independent medical education grant from Exact Sciences.
This is episode 3 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about the importance of primary care providers in identifying and managing patients at high risk for colorectal cancer.
In this episode: • David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University • Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center • Swati Patel, MD, associate professor and director of the Gastrointestinal Cancer Risk and Prevention Center at the University of Colorado School of Medicine Anschutz Medical Campus.
This season is supported by an independent medical education grant from Exact Sciences.
This is episode 6 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely discuss: • The role of the gastroenterologists and hepatologists, gastroenterology and hepatology advanced practice providers (APP), and others in a care team for obesity management. • How to find information on coding and reimbursement for obesity management. • How treating obesity is beneficial for patients and practices. • Pearls from episodes 1-5 of the series.
To collect CME credit for listening, visit agau.gastro.org.
This is episode 5 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this episode, our host Dr. Andres Acosta is joined by Dr. John Magaña Morton to discuss: • Evaluating patient outcomes and measuring weight loss success in terms of reduced disease burden. • How to adapt treatment plans when interventions are unsuccessful. • The future of obesity care in gastroenterology.
To collect CME credit for listening, visit agau.gastro.org.
This is episode 4 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this episode, our host Dr. Andres Acosta is joined by Dr. Barham Abu Dayyeh to discuss: • Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastroesophageal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. • Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss. • Updates on devices for obesity management that are available now and a look into what may be available in the future.
To collect CME credit for listening, visit agau.gastro.org.
This is episode 3 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this episode, our host Dr. Andres Acosta is joined by Dr. Janese Laster to discuss: • Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastroesophageal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. • Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss. • Updates on medications for obesity management that are available now and a look into what may be available in the future.
To collect CME credit for listening, visit agau.gastro.org.
This is episode 2 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Colleen Tewksbury to discuss: • A deep dive into dietary approaches for obesity management including debating low carb versus low fat diets. • Misconceptions that society has about dietary approaches to weight loss. • The importance of an individualized approach versus a cure-all for everyone.
To collect CME credit for listening, visit agau.gastro.org.
This is episode 1 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Naresh Gunaratnam to discuss: • Weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastrointestinal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. • Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss.
To collect CME credit for listening, visit agau.gastro.org.
Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting.
This is episode 3 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.
To collect CME credit for listening, visit nash.gastro.org.
This is episode 1 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care talk about the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. We start with a discussion on the prevalence of NAFLD and NASH and their clinical and economic burdens with guest Zobair Younossi, MD, president, medicine service line, Inova Health System.
To collect CME credit for listening, visit nash.gastro.org.
We close out this series chatting with Hashem El-Serag, MD, Baylor College of Medicine, about collaboration between primary care providers and specialists in managing patients with NAFLD and NASH.
This is the final episode in our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.
To collect CME credit for listening, visit nash.gastro.org.
Robert H. Eckel, MD, University of Colorado, discusses limitations in current data about managing NAFLD and NASH and emerging therapies.
This is episode 5 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.
To collect CME credit for listening, visit nash.gastro.org.
Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH.
This is episode 4 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.
To collect CME credit for listening, visit nash.gastro.org.
Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities.
This is episode 2 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.
To collect CME credit for listening, visit nash.gastro.org.
The NASH: Take Action! six-episode podcast series features interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome providing practical information for health care professionals on screening, diagnosing and managing these conditions. Collect up to 6 AMA PRA Category 1 credits for this activity by visiting nash.gastro.org.